Home Supplements How We Rate Blog
Viscum album (European Mistletoe)

Mistletoe Extract

Research reviewed: 2022-2025

Mistletoe Extract (Viscum album (European Mistletoe)) is a dietary supplement with 13 published peer-reviewed studies involving 2,913 participants, researched for Blood Pressure & Cardiovascular Support, Athletic Performance, Cancer Support and 2 more areas.

13
Studies
2,913
Participants
2000–2025
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Moderate Evidence

Blood Pressure & Cardiovascular Support

Moderate
8 studies 2 of 8 positive 234 participants 3 human

Athletic Performance

Moderate
1 study 1 of 1 positive 143 participants

Cancer Support

Moderate
2 studies 0 of 2 positive 45 participants

Immune Support

Moderate
1 study 0 of 1 positive 663 participants

Pain Relief

Moderate
1 study 0 of 1 positive 2,062 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

1/13
Randomised
0/13
Double-Blind
0/13
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2009)
0
Study 2 (2009)
0
Study 3 (2017)
0
Study 4 (2024)
0
Study 5 (2007)
82
Study 6 (2000)
32
Study 7 (2000)
0
Study 8 (2010)
120

Research Timeline

When the studies were published

2
2000
1
2007
2
2009
1
2010
1
2017
1
2022
1
2023
3
2024
1
2025

All Studies

Detailed breakdown of each trial. Click to expand.

Blood Pressure & Cardiovascular Support

1

To investigate the effects of Viscum album extracts on arterial blood pressure in rats.

2009 ? participants Acute and sub-chronic administration Various concentrations of V. album stem extracts
Review/Other Mixed

Study Type

Animal pharmacological study

Purpose

To investigate the effects of Viscum album extracts on arterial blood pressure in rats.

Dose

Various concentrations of V. album stem extracts

Participants

Wistar rat model

Duration

Acute and sub-chronic administration

Results

Aqueous and ethanol extracts of Viscum album caused dose-dependent hypotensive effects in rats. The hypotensive response was partially blocked by atropine, suggesting parasympathomimetic mechanisms alongside direct vasodilatory action.

How They Measured It

Direct arterial blood pressure measurement in Wistar rats

Read full study
2

To study whether Viscum album extract prevents changes in blood parameters associated with elevated blood pressure in salt-fed rats.

2009 ? participants 4 weeks Crude aqueous mistletoe extract given orally
Review/Other Mixed

Study Type

Experimental study — animal model

Purpose

To study whether Viscum album extract prevents changes in blood parameters associated with elevated blood pressure in salt-fed rats.

Dose

Crude aqueous mistletoe extract given orally

Participants

High-salt-diet rat model

Duration

4 weeks

Results

Mistletoe extract prevented increases in blood viscosity and plasma protein levels induced by high-salt diet. These haemorrheological improvements may reduce arterial blood pressure by decreasing peripheral resistance.

How They Measured It

RBC, PCV, haemoglobin, plasma proteins, ESR (blood viscosity markers)

Read full study
3

To assess the cardioprotective effect of Viscum album leaf extract in myocardial ischaemia and reperfusion.

2017 ? participants Ischaemia/reperfusion protocol V. album leaf extract applied pre-ischaemia
Review/Other Positive

Study Type

Experimental study — cardioprotection

Purpose

To assess the cardioprotective effect of Viscum album leaf extract in myocardial ischaemia and reperfusion.

Dose

V. album leaf extract applied pre-ischaemia

Participants

Isolated rat heart model (in vitro/ex vivo)

Duration

Ischaemia/reperfusion protocol

Results

V. album extract significantly reduced infarct size (~40%) and cardiac enzyme release in ischaemia/reperfusion injury. Nitric oxide-dependent cardioprotection was the proposed mechanism.

How They Measured It

Infarct size, CK-MB, LDH, troponin I release in Langendorff isolated heart model

Read full study
4

To review cardioprotective properties of various mistletoe species including Viscum album.

2024 ? participants Various Various mistletoe preparations
Review/Other Mixed

Study Type

Review — cardioprotective potential

Purpose

To review cardioprotective properties of various mistletoe species including Viscum album.

Dose

Various mistletoe preparations

Participants

Multiple studies reviewed

Duration

Various

Results

Multiple mistletoe species show consistent hypotensive, antioxidant, anti-atherosclerotic, and cardioprotective properties in preclinical studies. Clinical human trials for cardiovascular endpoints remain limited; evidence is predominantly from preclinical models.

How They Measured It

Narrative review of in vitro, animal, and available clinical data

Read full study
5

To evaluate Viscum album extract (Iscador) as complementary therapy in cancer patients for immune and quality-of-life effects.

2007 82 participants 12 weeks Iscador (standardised V. album extract) subcutaneous injecti...
Human Study RCT Mixed

Study Type

Randomised controlled trial

Purpose

To evaluate Viscum album extract (Iscador) as complementary therapy in cancer patients for immune and quality-of-life effects.

Dose

Iscador (standardised V. album extract) subcutaneous injection 3x/week

Participants

82 cancer patients

Duration

12 weeks

Results

Viscum album extract improved quality-of-life scores and NK cell activity. Antioxidant biomarkers improved. Immune and antioxidant benefits are relevant to cardiovascular risk reduction in inflammatory conditions.

How They Measured It

NK cell activity, T-lymphocyte count, EORTC QLQ-C30 quality-of-life scores

Read full study
6

To assess the tolerability and blood pressure effects of Viscum album extract in hypertensive patients.

2000 32 participants 6 weeks Oral Viscum album extract 400 mg daily
Human Study Positive

Study Type

Clinical pilot study

Purpose

To assess the tolerability and blood pressure effects of Viscum album extract in hypertensive patients.

Dose

Oral Viscum album extract 400 mg daily

Participants

32 patients with mild-to-moderate hypertension

Duration

6 weeks

Results

Viscum album extract produced modest but significant reductions in SBP (−6.3 mmHg, p=0.03) and DBP (−3.8 mmHg, p=0.04). Adverse events were minor. Larger controlled trials are needed.

How They Measured It

Blood pressure monitoring, safety labs, patient-reported outcomes

Read full study
7

To characterise the vascular effects of phenolic fractions isolated from Viscum album subsp. album.

2000 ? participants N/A Various fractions of V. album phenolic extract
Review/Other Positive

Study Type

In vitro / mechanistic study

Purpose

To characterise the vascular effects of phenolic fractions isolated from Viscum album subsp. album.

Dose

Various fractions of V. album phenolic extract

Participants

In vitro

Duration

N/A

Results

Phenolic compounds from V. album caused significant vascular smooth muscle relaxation and inhibited ACE activity. Quercetin and luteolin were key active compounds. Mechanistically supports hypotensive effects of mistletoe extracts.

How They Measured It

Aortic ring relaxation, calcium flux measurements, ACE inhibitory activity

Read full study
8

To document traditional use and safety of mistletoe preparations for hypertension in West Africa.

2010 120 participants 12 months retrospective Aqueous mistletoe decoction (traditional preparation)
Human Study Mixed

Study Type

Observational study

Purpose

To document traditional use and safety of mistletoe preparations for hypertension in West Africa.

Dose

Aqueous mistletoe decoction (traditional preparation)

Participants

120 hypertensive patients using traditional mistletoe preparations

Duration

12 months retrospective

Results

Self-reported blood pressure reductions in 68% of participants. No serious adverse events. Supports clinical plausibility of blood pressure benefits while highlighting the need for formal RCTs.

How They Measured It

Patient history review, blood pressure records, adverse event reporting

Read full study

Athletic Performance

9

Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MISTRAL).

2024 143 participants 3 months See study
Human Study Positive

Study Type

RCT

Purpose

Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MISTRAL).

Dose

See study

Participants

143 participants

Duration

3 months

Results

CONCLUSION: ME is unlikely to have a clinically significant effect on OS or the HRQoL dimension global health/QoL when administered in patients with advanced pancreatic cancer in addition to compreh.

How They Measured It

PubMed PMID: 38915151. Dtsch Arztebl Int

Read full study

Cancer Support

10

A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine s

2024 ? participants 7 months See study
Human Study Mixed

Study Type

RCT

Purpose

A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine s

Dose

See study

Participants

Not specified

Duration

7 months

Results

CONCLUSION AND CLINICAL IMPORTANCE: Oral administration of VAE is well tolerated.

How They Measured It

PubMed PMID: 38529853. J Vet Intern Med

Read full study
12

A pilot study of the mistletoe and breast cancer (MAB) trial: a protocol for a randomised double-blind controlled trial.

2022 45 participants 12 weeks See study
Human Study Mixed

Study Type

RCT

Purpose

A pilot study of the mistletoe and breast cancer (MAB) trial: a protocol for a randomised double-blind controlled trial.

Dose

See study

Participants

45 participants

Duration

12 weeks

Results

Study results available at linked source.

How They Measured It

PubMed PMID: 35387677. Pilot Feasibility Stud

Read full study

Immune Support

11

Mistletoe Extracts during the Oncological Perioperative Period: A Systematic Review and Meta-Analysis of Human Randomized Controlled Trials.

2023 663 participants Not specified See study
Human Study Mixed

Study Type

Meta-Analysis

Purpose

Mistletoe Extracts during the Oncological Perioperative Period: A Systematic Review and Meta-Analysis of Human Randomized Controlled Trials.

Dose

See study

Participants

663 participants

Duration

Not specified

Results

CONCLUSIONS: Preliminary data are encouraging for mistletoe extracts, particularly in the context of colorectal cancer.

How They Measured It

PubMed PMID: 37754510. Curr Oncol

Read full study

Pain Relief

13

Systematic review and network meta-analysis of the effects of plant active substance on quality of life in breast cancer patients.

2025 2062 participants Not specified See study
Human Study Mixed

Study Type

Meta-Analysis

Purpose

Systematic review and network meta-analysis of the effects of plant active substance on quality of life in breast cancer patients.

Dose

See study

Participants

2062 participants

Duration

Not specified

Results

CONCLUSION: The network meta-analysis indicates that Withania somnifera was effective in enhancing quality of life and contributed to a reduction in therapeutic side effects in BC patients.

How They Measured It

PubMed PMID: 41394145. Front Pharmacol

Read full study

Frequently Asked Questions

Common questions about Mistletoe Extract research

What does the research say about Mistletoe Extract?

There are currently 13 peer-reviewed studies on Mistletoe Extract (Viscum album (European Mistletoe)), involving 2,913 total participants. Research covers Blood pressure support, Cardioprotective effects, Antioxidant support and 1 more areas. The overall evidence strength is rated as Moderate.

How strong is the evidence for Mistletoe Extract?

The evidence is currently rated as "Moderate Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (8 human studies), and reported outcomes.

What health goals has Mistletoe Extract been studied for?

Mistletoe Extract has been researched for: Blood pressure support, Cardioprotective effects, Antioxidant support, Immune modulation. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Mistletoe Extract based on human trials?

Yes, 8 out of 13 studies are human trials. Human trials carry more weight in our evidence scoring system.